Guardian Pharmacy Services (GRDN) Receivables (2023 - 2026)

Guardian Pharmacy Services has disclosed Receivables across 4 years of filings, most recently posting $111.7 million for Q1 2026.

• Receivables for Q1 2026 came in at $111.7 million, up 14.68% year-over-year; the trailing twelve-month figure through Mar 2026 was $111.7 million (up 14.68% YoY), and the FY2025 annual result was $101.6 million, up 4.59% from the prior year.
• Receivables came in at $111.7 million for Q1 2026 at Guardian Pharmacy Services, up from $101.6 million in the prior quarter.
• In the past five years, Receivables ranged from a high of $111.7 million in Q1 2026 to a low of $77.3 million in Q4 2023.
• The 4-year median for Receivables is $97.3 million (2024), against an average of $97.0 million.
• Across the five-year window, Receivables climbed 25.74% in 2024 and advanced 4.59% in 2025, its largest moves.
• Guardian Pharmacy Services' Receivables stood at $77.3 million in 2023, then gained by 25.74% to $97.2 million in 2024, then advanced by 4.59% to $101.6 million in 2025, then grew by 9.93% to $111.7 million in 2026.
• The last three Receivables figures came in at $111.7 million (Q1 2026), $101.6 million (Q4 2025), and $106.2 million (Q3 2025), per Business Quant data.